Clara Burtenshaw

Clara Burtenshaw is an experienced legal and investment professional with a strong background in life sciences, biotech, and retail. Currently serving as Investor Director at Neurocentrx Pharma Ltd. and Board Advisor for the International Therapeutic Psilocybin Rescheduling Initiative, Clara Burtenshaw also holds the position of Partner and Investor at Neo Kuma Ventures, focusing on early-stage investments in impactful sectors. Previous roles include Global Legal Director at La Perla, Head of Legal at WHISTLES, and Group GC at TFG Brands, where significant contributions were made to the growth of a major private equity-backed fashion retail group. Clara Burtenshaw began a legal career at Slaughter and May, engaging in corporate law and M&A, and holds a Master of Laws from New York University School of Law and a Bachelor of Laws from the University of Oxford.